Tirzepatide consistently reduces bodyweight regardless of BMI before treatment, shows new analysis


A new analysis has found that tirzepatide, a drug used to treat obesity, consistently reduces body weight regardless of a patient’s BMI before treatment. This finding suggests that the drug may be effective for a wide range of individuals struggling with obesity. Cookies are used on the website for analytics, advertising, and to improve the user experience. By continuing to use the site, users agree to the use of cookies. More information can be found in the Cookie Policy and Cookie Settings.

Source link

error: Content is protected !!